GMO examines how years of ultra low interest rates inflated valuations across bond proxies, leveraged firms, and growth stocks. The paper argues even modest rate increases could trigger deratings, especially as heavily indebted companies now trade near market parity despite historically carrying 14% valuation discounts.
For Whom the Bond Tolls: Low Rate Beneficiaries in a Rising Rate Environment
GMO
Neil Constable, Rick Friedman
Research
8 Pages
Key Takeaways
Bond Proxy Valuations: High beta stocks tied to bonds traded at a 20% premium versus the market, with valuation spreads near 12 year extremes.
Leverage Risks Rising: Historically, heavily levered firms traded at a 14% discount, yet now trade near parity despite interest expense consuming roughly 50% of EBIT.
Growth Vulnerability Increasing: GMO estimates a 1% decline in 7 to 10 year Treasury bond prices could cause growth stocks to underperform the market by 0.5%.
Join our newsletter to have all of this content + Exclusive Newsletter Bonus Content delivered to your inbox every week
Related Content
